CSL’s first gene therapy for haemophilia B approved.
Boost for effected patients as HEMGENIX receives green light from European Commission CSL has revealed that the European Commission (EC) ...
Read moreDetailsBoost for effected patients as HEMGENIX receives green light from European Commission CSL has revealed that the European Commission (EC) ...
Read moreDetailsThis magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.
© 2023 - ArabHealthWorld all rights reserved